Determinants of PFOA Serum Half-Life after End of Exposure: A Longitudinal Study on Highly Exposed Subjects in the Veneto Region
Perfluoroalkyl substances (PFAS) are widely used, ubiquitous, and highly persistent man-made chemicals. Groundwater of a vast area of the Veneto Region (northeastern Italy) was found to be contaminated by PFAS from a manufacturing plant active since the late 1960s. As a result, residents were overex...
Saved in:
Published in | Environmental health perspectives Vol. 132; no. 2; p. 27002 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
National Institute of Environmental Health Sciences
01.02.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Perfluoroalkyl substances (PFAS) are widely used, ubiquitous, and highly persistent man-made chemicals. Groundwater of a vast area of the Veneto Region (northeastern Italy) was found to be contaminated by PFAS from a manufacturing plant active since the late 1960s. As a result, residents were overexposed to PFAS through drinking water until 2013, mainly to perfluorooctanoic acid (PFOA).
The aim of the present study was to estimate the rates of decline in serum PFOA and their corresponding serum half-lives, while characterizing their determinants.
We investigated 5,860 subjects more than 14 years of age who enrolled in the second surveillance round of the regional health surveillance program. Two blood samples were collected between 2017 and 2022 (average time between measurements: 4 years). Serum PFOA excretion rates and half-lives were estimated based on linear mixed effect models, modeling subject-specific serum PFOA concentrations over time and correcting for background concentrations. For modeling determinants of half-life [age, sex, body mass index (BMI), smoking-habit, alcohol consumption, and estimated glomerular filtration rate (eGFR)], we added interaction terms between each covariate and the elapsed time between measurements. Perfluorooctanesulfonate (PFOS) and perfluorohexanesulfonic acid (PFHxS) apparent half-lives were also estimated. A separate analysis was conducted in children (
). All analyses were stratified by sex.
Median initial serum concentrations of PFOA was
(range: 0.5-1,090), with a median reduction of 62.45%. The mean estimated PFOA half-life was 2.36 years [95% confidence interval (CI): 2.33, 2.40], shorter in women (2.04; 95% CI: 2.00, 2.08) compared to men (2.83; 95% CI: 2.78, 2.89). Half-lives varied when stratified by some contributing factors, with faster excretion rates in nonsmokers and nonalcohol drinkers (especially in males).
This study, to our knowledge the largest on PFOA half-life, provides precise estimates in young adults whose exposure via drinking water has largely ceased. For other PFAS, longer half-lives than reported in other studies can be explained by some ongoing exposure to PFAS via other routes. https://doi.org/10.1289/EHP13152. |
---|---|
AbstractList | Perfluoroalkyl substances (PFAS) are widely used, ubiquitous, and highly persistent man-made chemicals. Groundwater of a vast area of the Veneto Region (northeastern Italy) was found to be contaminated by PFAS from a manufacturing plant active since the late 1960s. As a result, residents were overexposed to PFAS through drinking water until 2013, mainly to perfluorooctanoic acid (PFOA).BACKGROUNDPerfluoroalkyl substances (PFAS) are widely used, ubiquitous, and highly persistent man-made chemicals. Groundwater of a vast area of the Veneto Region (northeastern Italy) was found to be contaminated by PFAS from a manufacturing plant active since the late 1960s. As a result, residents were overexposed to PFAS through drinking water until 2013, mainly to perfluorooctanoic acid (PFOA).The aim of the present study was to estimate the rates of decline in serum PFOA and their corresponding serum half-lives, while characterizing their determinants.OBJECTIVESThe aim of the present study was to estimate the rates of decline in serum PFOA and their corresponding serum half-lives, while characterizing their determinants.We investigated 5,860 subjects more than 14 years of age who enrolled in the second surveillance round of the regional health surveillance program. Two blood samples were collected between 2017 and 2022 (average time between measurements: 4 years). Serum PFOA excretion rates and half-lives were estimated based on linear mixed effect models, modeling subject-specific serum PFOA concentrations over time and correcting for background concentrations. For modeling determinants of half-life [age, sex, body mass index (BMI), smoking-habit, alcohol consumption, and estimated glomerular filtration rate (eGFR)], we added interaction terms between each covariate and the elapsed time between measurements. Perfluorooctanesulfonate (PFOS) and perfluorohexanesulfonic acid (PFHxS) apparent half-lives were also estimated. A separate analysis was conducted in children (n=480). All analyses were stratified by sex.METHODSWe investigated 5,860 subjects more than 14 years of age who enrolled in the second surveillance round of the regional health surveillance program. Two blood samples were collected between 2017 and 2022 (average time between measurements: 4 years). Serum PFOA excretion rates and half-lives were estimated based on linear mixed effect models, modeling subject-specific serum PFOA concentrations over time and correcting for background concentrations. For modeling determinants of half-life [age, sex, body mass index (BMI), smoking-habit, alcohol consumption, and estimated glomerular filtration rate (eGFR)], we added interaction terms between each covariate and the elapsed time between measurements. Perfluorooctanesulfonate (PFOS) and perfluorohexanesulfonic acid (PFHxS) apparent half-lives were also estimated. A separate analysis was conducted in children (n=480). All analyses were stratified by sex.Median initial serum concentrations of PFOA was 49 ng/mL (range: 0.5-1,090), with a median reduction of 62.45%. The mean estimated PFOA half-life was 2.36 years [95% confidence interval (CI): 2.33, 2.40], shorter in women (2.04; 95% CI: 2.00, 2.08) compared to men (2.83; 95% CI: 2.78, 2.89). Half-lives varied when stratified by some contributing factors, with faster excretion rates in nonsmokers and nonalcohol drinkers (especially in males).RESULTSMedian initial serum concentrations of PFOA was 49 ng/mL (range: 0.5-1,090), with a median reduction of 62.45%. The mean estimated PFOA half-life was 2.36 years [95% confidence interval (CI): 2.33, 2.40], shorter in women (2.04; 95% CI: 2.00, 2.08) compared to men (2.83; 95% CI: 2.78, 2.89). Half-lives varied when stratified by some contributing factors, with faster excretion rates in nonsmokers and nonalcohol drinkers (especially in males).This study, to our knowledge the largest on PFOA half-life, provides precise estimates in young adults whose exposure via drinking water has largely ceased. For other PFAS, longer half-lives than reported in other studies can be explained by some ongoing exposure to PFAS via other routes. https://doi.org/10.1289/EHP13152.CONCLUSIONSThis study, to our knowledge the largest on PFOA half-life, provides precise estimates in young adults whose exposure via drinking water has largely ceased. For other PFAS, longer half-lives than reported in other studies can be explained by some ongoing exposure to PFAS via other routes. https://doi.org/10.1289/EHP13152. Background: Perfluoroalkyl substances (PFAS) are widely used, ubiquitous, and highly persistent man-made chemicals. Groundwater of a vast area of the Veneto Region (northeastern Italy) was found to be contaminated by PFAS from a manufacturing plant active since the late 1960s. As a result, residents were overexposed to PFAS through drinking water until 2013, mainly to perfluorooctanoic acid (PFOA). OBJECTIVES: The aim of the present study was to estimate the rates of decline in serum PFOA and their corresponding serum half-lives, while characterizing their determinants. Methods: We investigated 5,860 subjects more than 14 years of age who enrolled in the second surveillance round of the regional health surveillance program. Two blood samples were collected between 2017 and 2022 (average time between measurements: 4 years). Serum PFOA excretion rates and half-lives were estimated based on linear mixed effect models, modeling subject-specific serum PFOA concentrations over time and correcting for background concentrations. For modeling determinants of half-life [age, sex, body mass index (BMI), smoking- habit, alcohol consumption, and estimated glomerular filtration rate (eGFR)], we added interaction terms between each covariate and the elapsed time between measurements. Perfluorooctanesulfonate (PFOS) and perfluorohexanesulfonic acid (PFHxS) apparent half-lives were also estimated. A separate analysis was conducted in children (n = 480). All analyses were stratified by sex. Results: Median initial serum concentrations of PFOA was 49 ng/mL (range: 0.5- 1,090), with a median reduction of 62.45%. The mean estimated PFOA half-life was 2.36 years [95% confidence interval (CI): 2.33, 2.40], shorter in women (2.04; 95% CI: 2.00, 2.08) compared to men (2.83; 95% CI: 2.78, 2.89). Half-lives varied when stratified by some contributing factors, with faster excretion rates in nonsmokers and nonalcohol drinkers (especially in males). Conclusions: This study, to our knowledge the largest on PFOA half-life, provides precise estimates in young adults whose exposure via drinking water has largely ceased. For other PFAS, longer half-lives than reported in other studies can be explained by some ongoing exposure to PFAS via other routes. Perfluoroalkyl substances (PFAS) are widely used, ubiquitous, and highly persistent man-made chemicals. Groundwater of a vast area of the Veneto Region (northeastern Italy) was found to be contaminated by PFAS from a manufacturing plant active since the late 1960s. As a result, residents were overexposed to PFAS through drinking water until 2013, mainly to perfluorooctanoic acid (PFOA). The aim of the present study was to estimate the rates of decline in serum PFOA and their corresponding serum half-lives, while characterizing their determinants. We investigated 5,860 subjects more than 14 years of age who enrolled in the second surveillance round of the regional health surveillance program. Two blood samples were collected between 2017 and 2022 (average time between measurements: 4 years). Serum PFOA excretion rates and half-lives were estimated based on linear mixed effect models, modeling subject-specific serum PFOA concentrations over time and correcting for background concentrations. For modeling determinants of half-life [age, sex, body mass index (BMI), smoking-habit, alcohol consumption, and estimated glomerular filtration rate (eGFR)], we added interaction terms between each covariate and the elapsed time between measurements. Perfluorooctanesulfonate (PFOS) and perfluorohexanesulfonic acid (PFHxS) apparent half-lives were also estimated. A separate analysis was conducted in children ( ). All analyses were stratified by sex. Median initial serum concentrations of PFOA was (range: 0.5-1,090), with a median reduction of 62.45%. The mean estimated PFOA half-life was 2.36 years [95% confidence interval (CI): 2.33, 2.40], shorter in women (2.04; 95% CI: 2.00, 2.08) compared to men (2.83; 95% CI: 2.78, 2.89). Half-lives varied when stratified by some contributing factors, with faster excretion rates in nonsmokers and nonalcohol drinkers (especially in males). This study, to our knowledge the largest on PFOA half-life, provides precise estimates in young adults whose exposure via drinking water has largely ceased. For other PFAS, longer half-lives than reported in other studies can be explained by some ongoing exposure to PFAS via other routes. https://doi.org/10.1289/EHP13152. |
Audience | Academic |
Author | Batzella, Erich Rosato, Isabella Russo, Francesca Fletcher, Tony Pitter, Gisella Da Re, Filippo Canova, Cristina |
Author_xml | – sequence: 1 givenname: Erich orcidid: 0000-0001-6849-7920 surname: Batzella fullname: Batzella, Erich – sequence: 2 givenname: Isabella surname: Rosato fullname: Rosato, Isabella – sequence: 3 givenname: Gisella surname: Pitter fullname: Pitter, Gisella – sequence: 4 givenname: Filippo surname: Da Re fullname: Da Re, Filippo – sequence: 5 givenname: Francesca surname: Russo fullname: Russo, Francesca – sequence: 6 givenname: Cristina surname: Canova fullname: Canova, Cristina – sequence: 7 givenname: Tony surname: Fletcher fullname: Fletcher, Tony |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38306197$$D View this record in MEDLINE/PubMed |
BookMark | eNqN0l1r2zAUBmAxOta0G-wXDMFgbBfu9GH5Y3ehS5dCIKXZeisU-9hRkaXUkqG520-fsjTrwnIxdGFhnvPC0Tln6MQ6Cwi9peSCsqL8PJneUE4Fe4FGVAiWlCVLT9CIkJImWZ6JU3Tm_T0hhBZZ9gqd8oKTjJb5CP38CgH6Tltlg8euwTdX8zFeQD90eKpMk8x0A1g1EeGJrbdi8rh2fujhCx7jmbOtDkMd6w1exMsGO4unul2ZzQ5CjRfD8h6qGK8tDivAd2AhOHwLrXb2NXrZKOPhzdP3HP24mny_nCaz-bfry_EsqQSjIakFF4SmwHNI0yJjJBOqypec58uCcWjqFGrCS0poCTkvgGWCKpGxCjKapg3wc_Rxl7vu3cMAPshO-wqMURbc4CUrGUvTssxJpO93tFUGpLaNC72qtlyO80JkQhS_VXJEtbG3Xpk4nkbH3wf-4oiPp4ZOV0cLPh0URBPgMbRq8F5eL27_387vDu2Hv-wKlAkr78wQ4jT8IXz39GTDsoNarnvdqX4j99vz3FLVO-97aGSlg9rmxNa0kZTI7XrK_Xo-D-FPwT7zH_oLMLjdkA |
CitedBy_id | crossref_primary_10_1016_j_envint_2024_108962 crossref_primary_10_3389_fpubh_2024_1418134 crossref_primary_10_3390_toxics12050314 crossref_primary_10_1289_EHP15486 crossref_primary_10_1016_j_ecoenv_2024_117395 crossref_primary_10_1289_EHP15099 |
Cites_doi | 10.1111/j.1742-7843.2007.00155.x 10.7326/0003-4819-150-9-200905050-00006 10.1289/EHP5337 10.1002/9781118861769 10.1016/j.scitotenv.2022.156891 10.1111/j.1753-4887.2011.00446.x 10.1021/acs.est.2c05555 10.1039/d0em00291g 10.1136/oemed-2011-100288 10.1289/EHP6785 10.1016/j.envint.2022.107274 10.1289/ehp.0901252 10.1016/j.envint.2021.106415 10.1016/j.ijheh.2021.113757 10.1016/j.envint.2022.107198 10.1016/j.ijheh.2010.03.007 10.1021/es401905e 10.1038/s41370-018-0094-1 10.1039/c9em00497a 10.1016/j.envint.2017.06.007 10.1016/j.scitotenv.2015.01.070 10.1016/j.envint.2021.106789 10.1016/j.envint.2019.105220 10.1016/j.envint.2019.105381 10.1136/oemed-2017-104651 10.1289/EHP10103 10.1017/S1368980012000080 10.1016/j.envint.2012.12.014 10.1016/j.envint.2017.10.026 10.1016/j.ijheh.2022.114040 10.1021/es500796y 10.1021/acs.est.6b01477 10.1289/ehp.1510391 10.1007/s00420-007-0213-0 10.1002/etc.4890 10.1016/j.envres.2022.112674 10.1186/s12937-016-0180-y 10.2131/jts.28.49 10.1016/j.envint.2020.105581 10.1289/ehp.1306613 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2024 National Institute of Environmental Health Sciences |
Copyright_xml | – notice: COPYRIGHT 2024 National Institute of Environmental Health Sciences |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM IOV ISR 7X8 |
DOI | 10.1289/EHP13152 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Gale In Context: Opposing Viewpoints Gale In Context: Science MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Public Health |
EISSN | 1552-9924 |
ExternalDocumentID | A785655870 38306197 10_1289_EHP13152 |
Genre | Journal Article |
GeographicLocations | Italy |
GeographicLocations_xml | – name: Italy |
GroupedDBID | --- -~X .GJ 04C 29G 2WC 2XV 36B 3O- 42X 4P2 53G 5GY 5RE 5VS 6PF 7RV 7WY 7X7 7XC 85S 88E 8AO 8C1 8FE 8FG 8FH 8FI 8FJ 8FL 8G5 8R4 8R5 9K5 AACGO AAFWJ AANCE AAWTL AAYXX ABBHK ABDBF ABJCF ABOCM ABPLY ABPPZ ABTLG ABUWG ABXSQ ACGFO ACHIC ACIHN ACIWK ACNCT ACPRK ACUHS ADBBV ADOJX ADQXQ ADRAZ ADULT AEAQA AENEX AEUPB AEUYN AEXZC AFKRA AFPKN AFRAH AGNAY AHDLI AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS AN0 ANHSF AOIJS AQVQM AS~ ATCPS AXR AZQEC B0M BAWUL BCNDV BENPR BES BEZIV BGLVJ BHPHI BKEYQ BKNYI BMSDO BNQBC BPHCQ BVXVI C1A CCPQU CITATION CS3 DCCCD DIK DU5 DWQXO E3Z EAD EAP EAS EBC EBD EBS EBX ECF ECGQY ECT EDH EHB EHC EHE EHN EIHBH EJD EMB EMK EMOBN EPL EPT ESX EX3 F5P F8P FRNLG FYUFA GNUQQ GROUPED_DOAJ GUQSH GX1 H13 HCIFZ HGD HMCUK HQ3 HTVGU HYE I-F IAG IAO IEA IEP IER IHR IHW INH INR IOF IOV IPO IPSME ISR ITC JAAYA JBMMH JENOY JHFFW JKQEH JLS JLXEF JPM JSG JST K60 K6~ K9- KQ8 L6V M0C M0R M1P M2O M48 M7S NAPCQ NEJ O5R O5S OK1 OVT P2P PATMY PCD PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQBIZ PQBZA PQGLB PQQKQ PROAC PSQYO PTHSS PV9 PYCSY Q2X QF4 QM9 QN7 QO4 Q~Q REH RGD RNS RPM RWL RZL S0X SA0 SJN SV3 TAE TAN TR2 TUS U5U UDP UGJ UKHRP WH7 WOQ WOW WQ9 XSB YR5 ZAC ZE2 ZGI ~02 ~8M ~KM CGR CUY CVF ECM EIF NPM PMFND 7X8 |
ID | FETCH-LOGICAL-c521t-d535014e37e44862065ac7b337b823efd4ed0391019e738e2651a562ce6144fe3 |
IEDL.DBID | M48 |
ISSN | 0091-6765 1552-9924 |
IngestDate | Fri Jul 11 08:26:09 EDT 2025 Tue Jun 17 22:14:12 EDT 2025 Fri Jun 13 00:01:53 EDT 2025 Tue Jun 10 21:11:45 EDT 2025 Fri Jun 27 06:04:54 EDT 2025 Fri Jun 27 05:47:36 EDT 2025 Thu May 22 21:24:14 EDT 2025 Thu Apr 03 07:03:00 EDT 2025 Tue Aug 05 11:59:39 EDT 2025 Thu Apr 24 23:05:04 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c521t-d535014e37e44862065ac7b337b823efd4ed0391019e738e2651a562ce6144fe3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0001-6849-7920 |
OpenAccessLink | https://ehp.niehs.nih.gov/doi/pdf/10.1289/EHP13152 |
PMID | 38306197 |
PQID | 2922449970 |
PQPubID | 23479 |
ParticipantIDs | proquest_miscellaneous_2922449970 gale_infotracmisc_A785655870 gale_infotracgeneralonefile_A785655870 gale_infotracacademiconefile_A785655870 gale_incontextgauss_ISR_A785655870 gale_incontextgauss_IOV_A785655870 gale_healthsolutions_A785655870 pubmed_primary_38306197 crossref_citationtrail_10_1289_EHP13152 crossref_primary_10_1289_EHP13152 |
PublicationCentury | 2000 |
PublicationDate | 2024-02-00 2024-Feb 20240201 |
PublicationDateYYYYMMDD | 2024-02-01 |
PublicationDate_xml | – month: 02 year: 2024 text: 2024-02-00 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Environmental health perspectives |
PublicationTitleAlternate | Environ Health Perspect |
PublicationYear | 2024 |
Publisher | National Institute of Environmental Health Sciences |
Publisher_xml | – name: National Institute of Environmental Health Sciences |
References | e_1_3_2_26_2 e_1_3_2_27_2 e_1_3_2_28_2 e_1_3_2_29_2 e_1_3_2_41_2 e_1_3_2_40_2 e_1_3_2_20_2 e_1_3_2_43_2 e_1_3_2_21_2 e_1_3_2_42_2 e_1_3_2_22_2 e_1_3_2_23_2 e_1_3_2_24_2 e_1_3_2_25_2 e_1_3_2_9_2 e_1_3_2_15_2 e_1_3_2_38_2 e_1_3_2_8_2 e_1_3_2_16_2 e_1_3_2_37_2 e_1_3_2_7_2 e_1_3_2_17_2 e_1_3_2_6_2 e_1_3_2_18_2 e_1_3_2_39_2 e_1_3_2_19_2 e_1_3_2_30_2 e_1_3_2_32_2 e_1_3_2_10_2 e_1_3_2_31_2 e_1_3_2_5_2 e_1_3_2_11_2 e_1_3_2_34_2 e_1_3_2_4_2 e_1_3_2_12_2 e_1_3_2_33_2 e_1_3_2_3_2 e_1_3_2_13_2 e_1_3_2_36_2 e_1_3_2_2_2 e_1_3_2_14_2 e_1_3_2_35_2 40085763 - Environ Health Perspect. 2025 Mar 14. doi: 10.1289/EHP17398. |
References_xml | – ident: e_1_3_2_34_2 doi: 10.1111/j.1742-7843.2007.00155.x – ident: e_1_3_2_16_2 doi: 10.7326/0003-4819-150-9-200905050-00006 – ident: e_1_3_2_13_2 doi: 10.1289/EHP5337 – ident: e_1_3_2_18_2 doi: 10.1002/9781118861769 – ident: e_1_3_2_32_2 doi: 10.1016/j.scitotenv.2022.156891 – ident: e_1_3_2_38_2 doi: 10.1111/j.1753-4887.2011.00446.x – ident: e_1_3_2_29_2 doi: 10.1021/acs.est.2c05555 – ident: e_1_3_2_2_2 doi: 10.1039/d0em00291g – ident: e_1_3_2_40_2 doi: 10.1136/oemed-2011-100288 – ident: e_1_3_2_8_2 doi: 10.1289/EHP6785 – ident: e_1_3_2_31_2 doi: 10.1016/j.envint.2022.107274 – ident: e_1_3_2_6_2 doi: 10.1289/ehp.0901252 – ident: e_1_3_2_42_2 doi: 10.1016/j.envint.2021.106415 – ident: e_1_3_2_9_2 doi: 10.1016/j.ijheh.2021.113757 – ident: e_1_3_2_11_2 doi: 10.1016/j.envint.2022.107198 – ident: e_1_3_2_19_2 doi: 10.1016/j.ijheh.2010.03.007 – ident: e_1_3_2_26_2 doi: 10.1021/es401905e – ident: e_1_3_2_4_2 doi: 10.1038/s41370-018-0094-1 – ident: e_1_3_2_10_2 doi: 10.1039/c9em00497a – ident: e_1_3_2_20_2 doi: 10.1016/j.envint.2017.06.007 – ident: e_1_3_2_39_2 doi: 10.1016/j.scitotenv.2015.01.070 – ident: e_1_3_2_23_2 doi: 10.1016/j.envint.2021.106789 – ident: e_1_3_2_37_2 doi: 10.1016/j.envint.2019.105220 – ident: e_1_3_2_7_2 doi: 10.1016/j.envint.2019.105381 – ident: e_1_3_2_17_2 doi: 10.1136/oemed-2017-104651 – ident: e_1_3_2_14_2 – ident: e_1_3_2_24_2 doi: 10.1289/EHP10103 – ident: e_1_3_2_41_2 doi: 10.1017/S1368980012000080 – ident: e_1_3_2_27_2 doi: 10.1016/j.envint.2012.12.014 – ident: e_1_3_2_15_2 doi: 10.1016/j.envint.2017.10.026 – ident: e_1_3_2_25_2 – ident: e_1_3_2_43_2 doi: 10.1016/j.ijheh.2022.114040 – ident: e_1_3_2_28_2 doi: 10.1021/es500796y – ident: e_1_3_2_21_2 doi: 10.1021/acs.est.6b01477 – ident: e_1_3_2_36_2 doi: 10.1289/ehp.1510391 – ident: e_1_3_2_22_2 doi: 10.1007/s00420-007-0213-0 – ident: e_1_3_2_3_2 doi: 10.1002/etc.4890 – ident: e_1_3_2_12_2 doi: 10.1016/j.envres.2022.112674 – ident: e_1_3_2_35_2 doi: 10.1186/s12937-016-0180-y – ident: e_1_3_2_33_2 doi: 10.2131/jts.28.49 – ident: e_1_3_2_5_2 doi: 10.1016/j.envint.2020.105581 – ident: e_1_3_2_30_2 doi: 10.1289/ehp.1306613 – reference: 40085763 - Environ Health Perspect. 2025 Mar 14. doi: 10.1289/EHP17398. |
SSID | ssj0001866 |
Score | 2.5255177 |
Snippet | Perfluoroalkyl substances (PFAS) are widely used, ubiquitous, and highly persistent man-made chemicals. Groundwater of a vast area of the Veneto Region... Background: Perfluoroalkyl substances (PFAS) are widely used, ubiquitous, and highly persistent man-made chemicals. Groundwater of a vast area of the Veneto... |
SourceID | proquest gale pubmed crossref |
SourceType | Aggregation Database Index Database Enrichment Source |
StartPage | 27002 |
SubjectTerms | Alkanesulfonic Acids Ammonium perfluorooctanoate Analysis Caprylates Child Drinking water Drinking Water - chemistry Environmental Exposure - analysis Environmental Pollutants Female Fluorocarbons Half-Life Health aspects Humans Longitudinal Studies Male Water Pollutants, Chemical - analysis Water, Underground Young Adult |
Title | Determinants of PFOA Serum Half-Life after End of Exposure: A Longitudinal Study on Highly Exposed Subjects in the Veneto Region |
URI | https://www.ncbi.nlm.nih.gov/pubmed/38306197 https://www.proquest.com/docview/2922449970 |
Volume | 132 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9NAEF71cUFCCMorUMIUIXoyrb2210GqqlAcAuojCqTKzXLs2apSsEsdS82Nn86M10nrKodefNnPkr3jmf1mPfuNEB9tO6WB_X1rQquP5RKhsAJXKkvL2HESFkjXvN9xcur3R-7PsTdeE4tum_UEFitTO-4nNbqefr75Oz8khz-otBGCzl7YH9iS1qF1sUnrkWL3PHFvNcNZ0s1oUdqWr3yvlqC9e2djUbofmu8Rzmrh6T0VT2rGCF1j4mdiDbMt8dhst4E5RfRc_Pt2p6wFcg2D3lkXKBCUf6AfT7V1fKkRqobgEGYpI8Kbq5y3B79AF45zbltUptwiC7i0cA55BlwDMp0bIKZAMYY3bQq4zIBoI5xTmJzlMEQuaX4hRr3w91HfqpsrWAn3MLBSr_qliFIhZWi-Q1QkTtRESkVWk6hTF1NWjycKiEoG6PieHRNZSpBTSI3ypdjI8gxfC0icGImHaSSuQtmlG7CR0ZXI9IDyvZbYXcxulNTK49wAYxpxBkJ2iBZ2aImdJfLKqG2swLxnA0XmnOjSQaOuCoicehR_WuJDhWB5i4zrZy7isiiiH2fnDwD9GjZAuzVI5_TESVyfWaD3ZtmsBvJTA3lhRMNXAbcbQPLmpDG8s_juIh7iErgM87KInA5NJ-WnjHllPsjlHMmAMj-7o9485KXeikcOMTNTer4tNmbXJb4jZjWbtMW6Giu6Bkc2X3vf22Lza3g6GLarvYp25Vj_AZdHIRw |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Determinants+of+PFOA+Serum+Half-Life+after+End+of+Exposure%3A+A+Longitudinal+Study+on+Highly+Exposed+Subjects+in+the+Veneto+Region&rft.jtitle=Environmental+health+perspectives&rft.au=Batzella%2C+Erich&rft.au=Rosato%2C+Isabella&rft.au=Pitter%2C+Gisella&rft.au=Re%2C+Filippo+Da&rft.date=2024-02-01&rft.pub=National+Institute+of+Environmental+Health+Sciences&rft.issn=0091-6765&rft.volume=132&rft.issue=2&rft_id=info:doi/10.1289%2FEHP13152&rft.externalDBID=ISR&rft.externalDocID=A785655870 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0091-6765&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0091-6765&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0091-6765&client=summon |